Description
Retatrutide is a synthetic triple-agonist peptide researched for receptor-binding activity across metabolic signaling pathways. In laboratory studies, it is analyzed for interaction within GLP-1, GIP, and glucagon receptor models. Each vial contains 20mg lyophilized peptide manufactured for purity. Strictly intended for research purposes only.






Reviews
There are no reviews yet.